| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE | 17 |
| 1 | ASPIRIN | 15 |
| 2 | ASPIRIN 325 MG | 14 |
| 3 | ASPIRIN 81 MG | 14 |
| 4 | DICLOFENAC SODIUM | 11 |
| 5 | ADALIMUMAB | 10 |
| 6 | METFORMIN | 10 |
| 7 | METFORMIN ER 500 MG | 10 |
| 8 | METFORMIN ER 750 MG | 10 |
| 9 | CALCIUM | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLYBURIDE AND METFORMIN HYDROCHLORIDE | 1 | 0.0046 |
| 1 | BARICITINIB | 4 | 0.0013 |
| 2 | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | 1 | 0.0012 |
| 3 | APOMORPHINE HYDROCHLORIDE | 1 | 0.0006 |
| 4 | EDOXABAN TOSYLATE | 3 | 0.0004 |
| 5 | CICLESONIDE | 6 | 0.0004 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 7 | PATISIRAN | 1 | 0.0004 |
| 8 | SENNOSIDES AND DOCUSATE SODIUM | 1 | 0.0003 |
| 9 | IOPAMIDOL | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 2 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Interleukin-1 Receptor Antagonist [EPC] | 4 | 0.0002 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 6 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 7 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 8 | PCSK9 Inhibitor [EPC] | 2 | 0.0001 |
| 9 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |